Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lindgren

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 11, 2008
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillationAnna Ringborg, Robby Nieuwlaat, Peter Lindgren, et al.
Pharmacoeconomics|October 28, 2016
A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering TherapiesChing-Yun Wei, Ruben G W Quek, Guillermo Villa, et al.
JAMA Cardiology|August 24, 2017
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular DiseaseGregg C Fonarow, Anthony C Keech, Terje R Pedersen, et al.
Frontiers in Pharmacology|September 5, 2025
The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapiesSteven Simoens, David Dodwell, Michael Hartevelt, et al.
Frontiers in Pharmacology|September 22, 2025
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapiesSteven Simoens, David Dodwell, Michael Hartevelt, et al.
European Journal of Human Genetics : EJHG|May 14, 2015
A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9Emma Tham, Erik A Eklund, Anna Hammarsjö, et al.
Frontiers in Oncology|April 27, 2026
HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer: study protocol of a multicenter, prospective, open-label trialRenske Altena, Oscar P B Wiklander, Nour Susaeg Romdhani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLena Sannemann, Hanneke F M Rhodius-Meester, Mats Ekelund, et al.
Frontiers in Neurology|August 21, 2023
Precision medicine in neurodegeneration: the IHI-PROMINENT projectAshley Tate, Marc Suárez-Calvet, Mats Ekelund, et al.
European Urology|May 24, 2024
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in EuropePieter Vynckier, Lieven Annemans, Sarah Raes, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 11, 2008
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillationAnna Ringborg, Robby Nieuwlaat, Peter Lindgren, et al.
Pharmacoeconomics|October 28, 2016
A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering TherapiesChing-Yun Wei, Ruben G W Quek, Guillermo Villa, et al.
JAMA Cardiology|August 24, 2017
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular DiseaseGregg C Fonarow, Anthony C Keech, Terje R Pedersen, et al.
Frontiers in Pharmacology|September 5, 2025
The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapiesSteven Simoens, David Dodwell, Michael Hartevelt, et al.
Frontiers in Pharmacology|September 22, 2025
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapiesSteven Simoens, David Dodwell, Michael Hartevelt, et al.
European Journal of Human Genetics : EJHG|May 14, 2015
A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9Emma Tham, Erik A Eklund, Anna Hammarsjö, et al.
Frontiers in Oncology|April 27, 2026
HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer: study protocol of a multicenter, prospective, open-label trialRenske Altena, Oscar P B Wiklander, Nour Susaeg Romdhani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsLena Sannemann, Hanneke F M Rhodius-Meester, Mats Ekelund, et al.
Frontiers in Neurology|August 21, 2023
Precision medicine in neurodegeneration: the IHI-PROMINENT projectAshley Tate, Marc Suárez-Calvet, Mats Ekelund, et al.
European Urology|May 24, 2024
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in EuropePieter Vynckier, Lieven Annemans, Sarah Raes, et al.
Pageof 17